Literature DB >> 20125006

High-density lipoprotein metabolism and endothelial function.

Charles J Lowenstein1, Scott J Cameron.   

Abstract

PURPOSE OF REVIEW: High-density lipoprotein (HDL) protects against atherosclerosis, transporting cholesterol from peripheral cells to the liver, where it is excreted into the bile. However, HDL also has prominent vascular protective effects. RECENT
FINDINGS: Recent studies have uncovered mechanisms through which HDL decreases vascular inflammation, boosts nitric oxide production, and inhibits thrombosis. The discovery that dysfunctional HDL can also have proinflammatory effects has uncovered a new aspect of HDL biology.
SUMMARY: Low-density lipoprotein is the primary target for drug therapy of dyslipidemias. Drugs that increase HDL also affect additional metabolic pathways. Development of selective drugs targeting key aspects of HDL metabolism may enable us to alter the composition of HDL and inhibit atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125006     DOI: 10.1097/MED.0b013e32833727ee

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  6 in total

1.  Current serum lipoprotein levels and FMRI response to working memory in midlife.

Authors:  Mitzi M Gonzales; Takashi Tarumi; Danielle E Eagan; Hirofumi Tanaka; Fedora O Biney; Andreana P Haley
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-13       Impact factor: 2.959

Review 2.  The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Authors:  Susan Yuditskaya; Anthony F Suffredini; Gregory J Kato
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

Review 3.  Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL.

Authors:  Baohai Shao
Journal:  Biochim Biophys Acta       Date:  2011-12-10

4.  Associations of metabolic factors and adipokines with pain in incipient upper extremity soft tissue disorders: a cross-sectional study.

Authors:  Martti Rechardt; Rahman Shiri; Harri Lindholm; Jaro Karppinen; Eira Viikari-Juntura
Journal:  BMJ Open       Date:  2013-08-19       Impact factor: 2.692

5.  Clustering of the metabolic syndrome components in adolescence: role of visceral fat.

Authors:  Melkaye G Melka; Michal Abrahamowicz; Gabriel T Leonard; Michel Perron; Louis Richer; Suzanne Veillette; Daniel Gaudet; Tomáš Paus; Zdenka Pausova
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

6.  Type 2 diabetes is associated with loss of HDL endothelium protective functions.

Authors:  Tomáš Vaisar; Erica Couzens; Arnold Hwang; Michael Russell; Carolyn E Barlow; Laura F DeFina; Andrew N Hoofnagle; Francis Kim
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.